Dietary Salt in Rheumatoid Arthritis
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT03649178
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- salt — OTHERParticipants will randomly eat a high salt diet for 8 weeks and a low salt diet for 8 weeks
Study Details
In this study investigators propose to address the following hypotheses: 1) Reduction in dietary sodium will decrease inflammation in patients with rheumatoid arthritis (RA). 2) Reduction in dietary sodium will decrease blood pressure in patients with RA. 3) Reduction in dietary sodium will decrease tissue sodium in patients with RA.
Key Dates
- Start date
- Jan 2, 2020
- Status verified
- Oct 2025
- Primary completion
- Sep 30, 2024
- Completion
- Dec 30, 2024
Study Design
- Enrollment
- 18 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Other: low salt dietlow-sodium diet (50mmol/24hours x 8 weeks ) Subjects will choose a rotation of low-sodium meals from a predetermined list from a commercial vendor (Mom's Meals) that will be used to provide 2 meals (lunch and dinner)/day that the vendor will deliver at approximately 7 day intervals. Staff of the Vanderbilt Diet,Body Composition, and Human Metabolism Core determine breakfast and snacks appropriate for theHS andLS diets and provide instructions to subjects.
- Other: high salt diethigh-sodium diet (200mmol/24hours x 8weeks) Subjects will choose a rotation of low-sodium meals from a predetermined list from a commercial vendor (Mom's Meals) that will be used to provide 2 meals (lunch and dinner)/day that the vendor will deliver at approximately 7 day intervals. Staff of the Vanderbilt Diet,Body Composition, and Human Metabolism Core determine breakfast and snacks appropriate for theHS andLS diets and provide instructions to subjects.
Primary Outcome Measure
Change in Tissue Sodium [ Time Frame: 2 scans, one at end of week 8, and one at end of week 20 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | - |
Find similar trials in Nashville, TN
By condition
By research site
Related Studies
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- G7 Freedom Constrained Vivacit-E LinersEnrolling By Invitation · Zimmer Biomet · Birmingham, Alabama
- Exactech Shoulder Post Market Clinical Follow-up StudyRecruiting · Exactech · Laguna Woods, California
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPHASE2 · Recruiting · AbbVie · Peoria, Arizona